Gladius Capital Management’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-348	Closed	-$22.1K	–	331
2023 Q2	$22.1K	Sell	348 -202	-37%	-$12.8K	﹤0.01%	209
2023 Q1	$26K	Buy	+550	New	+$26K	﹤0.01%	222